Zobrazeno 1 - 10
of 33
pro vyhledávání: ''
Autor:
Zhengdong Fang, Guangwei Yang, Zhenjie Liu, Wan Zhang, Li Yin, Zhenyu Shi, Linjun Wang, Jianing Yue, Libin Zhang, Yuefeng Zhu, Bin Gao, Miaomiao Li, Lubin Li, Xueying Ke, Zheng Gu, Wei Han
Publikováno v:
BMJ Open, Vol 11, Iss 10 (2021)
BMJ Open
BMJ Open
IntroductionInferior vena cava (IVC) filters are commonly used in patients with venous thromboembolism to prevent fatal pulmonary embolism, but the thrombosis risk increases after filter placement. Warfarin is a widely anticoagulant, but long-term mo
Autor:
Piotr Adamski, Wojciech Wojakowski, Aldona Kubica, Klaudiusz Nadolny, Piotr Niezgoda, Eliano Pio Navarese, Jacek Kubica, Maciej Lesiak, Katarzyna Buszko, Andrzej Kleinrok, Agata Kosobucka, Jarosław Gorący, Mariusz Gasior
Publikováno v:
BMJ Open
BMJ Open, Vol 11, Iss 3 (2021)
BMJ Open, Vol 11, Iss 3 (2021)
IntroductionThe unfavourable influence of morphine on the pharmacokinetics of ticagrelor resulting in weaker and retarded antiplatelet effect in patients with acute coronary syndrome (ACS) has been previously shown. Replacing morphine with methoxyflu
Autor:
Duk-Woo Park, Mao-Shin Lin, Hyun Jung Koo, Wei Hsian Yin, Do Yoon Kang, Simon Cheung Chi Lam, Seung Chai Jung, Seung-Jung Park, Won Kim, Jung-Min Ahn, Euihong Ko, Hanbit Park, Jeng Wei, Tsung Yu Ko, Kyung Won Kim, Joon-Won Kang, Dong Hyun Yang, Yung Tsai Lee, Jae Hong Lee, Se Hun Kang, Anthony Y.T. Wong, Hsien-Li Kao, Sung Cheol Yun, Dae-Hee Kim
Publikováno v:
BMJ Open
BMJ Open, Vol 11, Iss 1 (2021)
BMJ Open, Vol 11, Iss 1 (2021)
IntroductionOptimal antithrombotic strategy following transcatheter aortic valve replacement (TAVR) is still unknown. We hypothesised that the direct factor Xa inhibitor edoxaban can potentially prevent subclinical leaflet thrombosis and cerebral emb
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 12 (2020)
BMJ Open, Vol 10, Iss 12 (2020)
ObjectivesThe objective of this study is to examine the temporal trend of antiplatelet prescribing pattern during index hospitalisation discharge in Hong Kong (HK) acute coronary syndrome (ACS) population.DesignThe study is a retrospective observatio
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
BMJ Open
BMJ Open
ObjectivesTo evaluate the short-term (12 weeks) safety and utilisation of rivaroxaban prescribed to new-user adult patients for the treatment of deep vein thrombosis and pulmonary embolism and for the prevention of recurrent deep vein thrombosis and
Autor:
Li Yang, Jingjing Wu
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 7 (2020)
BMJ Open, Vol 10, Iss 7 (2020)
ObjectiveLimited economic evaluation data for rivaroxaban compared with standard of care (SoC) exists in China. The objective of this analysis was to evaluate the cost-effectiveness of rivaroxaban compared with current SoC (enoxaparin overlapped with
Autor:
J. Simon Bell, Jenni Ilomäki, Kenneth K.C. Man, Gary Tse, Ian C. K. Wong, Hassan Alwafi, Gang Fang, Abdallah Y Naser, Pajaree Mongkhon, Li Wei
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
BMJ Open
BMJ Open
ObjectiveTo evaluate oral anticoagulant (OAC) prescribing trends in type 2 diabetes mellitus (T2DM) in the UK from 2001 to 2015.DesignA cross-sectional drug utilisation study.SettingElectronic health records from The Health Improvement Network primar
Autor:
Ji'e Yang, Junbo Ge, Ruifen Cao, Ming Zheng, Yuxiang Dai, Chenguang Li, Hongbo Yang, Feng Zhang, Juying Qian, Kang Yao
Publikováno v:
BMJ Open
IntroductionDual antiplatelet therapy (DAPT) with aspirin and thienopyridine is required after placement of coronary stents to prevent thrombotic complications. However, current recommendation for duration of DAPT remains controversial. Firehawk is a
Autor:
Ying Qin, Jie Han, Zhihui Zhu, Kun Liu, Yuehuan Li, Yan Li, Jinglun Shen, Xu Meng, Haibo Zhang
Publikováno v:
BMJ Open
IntroductionWarfarin is an effective anticoagulant and the only oral anticoagulant available for patients with mechanical heart valves. The prothrombin time and the associated international normalised ratio (INR) are routinely tested to monitor the r
Publikováno v:
BMJ Open
IntroductionWarfarin is widely used in the world as oral anticoagulant, but it is difficult to manage patients after medication due to its narrow treatment window and individualised differences. Therefore, every region uses network means to carry out